ARCHIVES

An “insurgency” targets randomized trials, demands access to investigational drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

Congress Approves Payments For Treatment Of Women Diagnosed In CDC Program.

October 13, 2000

Breast Implants Don’t Cause Tissue Disorders, NCI Finds

October 29, 2004

Toxicity, Non-Cancer Deaths Increase With Combo Therapy

July 30, 2010

Smokers Quitlines Found Effective Regardless of Recruitment Method

June 24, 2011

Investigator Initiated Clinical Research Gets More For Less Money, Carbone Contends

April 13, 1979

Sen. Feinstein To Introduce New National Cancer Act.

February 22, 2002